MN
Michael Nally
Partner at Flagship Pioneering
Boston, Massachusetts
Overview
Michael Nally is currently serving as the CEO at Generate Biomedicines and as a CEO/Partner at Flagship Pioneering in Boston, Massachusetts. With a track record of success in the pharmaceutical industry, he has held key leadership positions at Merck, including Chief Marketing Officer and President of Merck Vaccines, showcasing his expertise in sales effectiveness, product launch, and market access.
Nally's career highlights include leading Generate Biomedicines to Series C funding and holding various executive roles at Merck, demonstrating his strategic leadership in driving business growth and innovation within the life sciences sector.
Work Experience
CEO at Generate Biomedicines
2021 - Current
CEO/Partner
2021
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Board Member
2021
Member Board Of Directors
2022
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
Raised $190,000,000.00 from Pictet Private Equity Investors S.A., M&G Investments, Flagship Pioneering, Partners Investment, Catalyst and Modi Ventures.
Chief Marketing Officer, Human Health
2019 - 2021
President, Merck Vaccines
2016 - 2019
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Raised $5,586,000.00 from Private Capital Advisors.
Managing Director, UK and Ireland
2014 - 2016
Managing Director, Sweden
2011 - 2013
Executive Director, Strategic Initiatives and Operations
2011 - 2011
Executive Director, Global Human Health Operations and Execution
2009 - 2010
Director Business Development
2008 - 2009
Director, Investor Relations
2006 - 2008
Manager, Worldwide Human Health Financial Services
2005 - 2006
Senior Financial Analyst, Corporate Financial Services
2003 - 2005
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Raised $5,586,000.00 from Private Capital Advisors.